O2- O2 Alterations Induced by Endotoxin
Correlate with Severity of Mitochondrial Injury
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Sepsis is usually associated with altered O2 metabolism in systemic organs. Until recently, inadequate O2 delivery was thought to be the putative mechanism underlying these metabolic alterations. However, current investigations suggest that impaired O2 consumption due to disrupted O2
use by mitochondria may be the culprit. Therefore, we hypothesized that endotoxin (LPS)-induced
O2-
O2 alterations would correlate with the severity of mitochondrial injury in a systemic organ
(i.e., the ileum). Using an in situ autoperfused feline ileum preparation, we assessed
O2-
O2 relationships and mitochondrial ultrastructure after 2 h in LPS-treated (3 mg/kg, intravenous; n = 11)
and time-matched control (n = 5) animals. Mitochondrial injury was graded in a blinded fashion on
the basis of characteristics associated with established stages of cell injury. LPS-treated animals developed severe mitochondrial injury in the ileal mucosa despite unchanged regional tissue perfusion and ileal oxyhemoglobin levels compared with controls. Worsening of mitochondrial injury correlated with increases in the critical O2 delivery (r = 0.85; p < 0.002) and decreases in the maximum O2 extraction (r =
0.61; p < 0.02) in the ileum. These results suggest that mitochondrial injury,
leading to impaired O2 utilization, may be primarily responsible for altered
O2-
O2 relationships in
systemic organs during sepsis.
| |
INTRODUCTION |
|---|
|
|
|---|
Sepsis is a major cause of morbidity and mortality affecting an
estimated 500,000 persons annually at a cost of $5-10 billion among hospital patients, in the United States alone (1, 2). The
high mortality of patients with sepsis (20-40%) correlates with
the extent and severity of systemic organ injury (3) and the development of altered oxygen metabolism (4, 5). Alterations of
oxygen metabolism during critical illness have been well documented and are characterized by impaired tissue oxygen extraction and a "pathologic" dependency of oxygen consumption (
O2) on oxygen delivery (
O2) (4, 5).
The putative mechanism for altered oxygen metabolism
during sepsis and other acute illnesses relates to insufficient
tissue oxygen delivery (4, 5). However, previous investigations by ourselves (6) and others (9) suggest that altered oxygen metabolism during sepsis is not sufficiently explained by
impaired oxygen delivery to the tissues. Instead, it is possible
that, in addition to altered metabolism of glucose, proteins,
and lipids (13), sepsis is associated with disruption of oxygen-consuming pathways. This notion is supported by clinical trials
wherein augmentation of systemic oxygen delivery did not improve outcome in critically ill patients with established sepsis
(14, 15). These observations led us to examine the possibility that sepsis-induced alterations of oxygen metabolism, such
as
O2-
O2 alterations, may result from damage to oxygen-
using intracellular organelles, the most significant being the mitochondria.
In animal models of sepsis, other investigators have shown
that sepsis is associated with mitochondrial dysfunction (16) and ultrastructural evidence of mitochondrial injury (17, 18). However, these studies were not designed to prevent tissue
hypoxia through resuscitative measures (e.g., fluid or blood
transfusion) and did not monitor for changes in
O2-
O2 relationships that are characteristic of sepsis and other critical
illnesses (4, 5). Thus, the relationship between mitochondrial
injury and sepsis-induced alterations of oxygen metabolism
has not been defined.
The present study was designed, therefore, to test the hypothesis that sepsis-induced alterations of oxygen metabolism
correlate with the extent and severity of mitochondrial injury.
To test this hypothesis, we used the in situ autoperfused feline
ileum preparation to examine simultaneously ileal
O2-
O2
relationships and mitochondrial ultrastructure 2 h after intravenous endotoxin (LPS) administration and in time-matched
control animals. In support of the hypothesis, the results indicated that LPS-induced
O2-
O2 alterations in the ileum correlated with the severity of mitochondrial injury. Although
causality was not verified, the association between LPS-
induced
O2-
O2 alterations and mitochondrial injury suggests that sepsis-induced alterations in oxygen metabolism
may be the result of impaired intracellular oxygen use.
| |
METHODS |
|---|
|
|
|---|
Animal Preparation
The preparation used for this study has been described previously (6-
8). Briefly, having been fasted overnight, random source male cats
were anesthetized with intramuscular ketamine-HCl (25 mg/kg) and
intravenous sodium pentobarbital (10 mg/kg). All animals had a
cuffed endotracheal tube placed via tracheostomy and were mechanically ventilated. A carotid artery and a femoral artery and vein were
then cannulated. The femoral artery cannula was connected to a pressure transducer linked to a chart recorder to enable continuous monitoring of arterial pressure (
). All arterial and venous blood samples taken during the experiment were withdrawn into heparinized
syringes and processed immediately for measurement of pH, PCO2,
and PO2, using a blood gas analyzer (ABL3; Radiometer America,
Westlake, OH), and for hemoglobin concentration and oxygen saturation and content using a co-oximeter (OSM3; Radiometer America)
that was specifically calibrated for feline blood. Fluids lost owing to
insensible water loss and blood sample acquisition were replenished
by administering buffered isotonic saline via the femoral vein [5-10
(ml/kg)/h]. Finally, rectal temperature was monitored throughout the
experiment and maintained at 39° C.
Surgical Procedure
After a midline abdominal incision, the spleen and omentum were carefully retracted, and a 40- to 50-g segment of ileum, with its blood and lymph supply intact, was isolated. After resecting the remainder of the small and large intestines, the superior mesenteric artery was cannulated and perfused via a connection made with the carotid artery cannula. The superior mesenteric vein was then cannulated (PE 240 tubing, 1.67-mm i.d.), and the effluent was collected in a reservoir. Using an extracorporeal circuit that was primed with heparinized, white cell-free blood from a donor cat, the venous effluent was reinfused via the femoral vein. Venous pressures were maintained at 0 mm Hg throughout the experiment. Finally, continuous measurement of superior mesenteric venous blood flow was provided through an inline flow probe with the meter connected to the chart recorder.
Reagents
Lipopolysaccharide (LPS) from Escherichia coli (serotype 0127:B8; Sigma, St. Louis, MO) was dissolved in buffered isotonic saline and used at a concentration of 1.0 mg/ml.
Experimental Protocol
On completion of the surgical procedures and after a ~ 30 to 40-min
period over which the ileal preparation was allowed to stabilize, ileal
samples were taken for later electron microscopy analysis (described
below). After another ~ 15-min stabilization period, baseline measurements (PaO2, PaCO2, arterial pH, total Hb (hemoglobin), HbO2
[oxyhemoglobin], SaO2, O2 content,
, and superior mesenteric
venous blood flow) were obtained. Animals were then randomly assigned to two treatment groups: an experimental group (n = 11) that
received intravenous LPS (3.0 mg/kg) as prepared above, and a time-matched control group (n = 5) that received intravenous buffered isotonic saline alone in a volume matching the LPS dose. All animals
were observed and maintained over time, and evaluated experimentally at 2 h posttreatment.
In all groups, PaCO2 and PaO2 were kept within normal limits (6, 7)
by adjusting the fraction of inspired oxygen (FIO2) and minute ventilation as needed. In addition, a normal arterial pH was maintained by
administering bicarbonate intravenously as needed. The PaO2-to-FIO2
ratio was determined at baseline (time 0) and at hourly intervals
thereafter, with the FIO2 increased from that of room air (21% O2) to
1.0 (100% O2) for approximately 10 min. Additional donor blood was
administered via the extracorporeal circuit, as necessary, to maintain
above 90 mm Hg. All measurements taken at baseline were repeated after 2 h, and then ileal tissue samples needed for electron microscopy analysis (described below) were obtained. After the injection
of colored microspheres (described below) to evaluate ileal perfusion
at 2 h posttreatment and ~ 10 min for them to distribute, ileal
O2-
O2 determinations were made (described below). Measurements of
ileal HbO2 content were made in vivo every 15 min by reflectance
spectrophotometry (described below). At the completion of the experiment, samples of ileum were taken for determination of ileal perfusion (described below), and then all animals were given a lethal intravenous injection of sodium pentobarbital.
Ileal Oxyhemoglobin Content Measurements
Ileal HbO2 contents were measured in vivo at baseline and every 15 min by reflectance spectrophotometry. This technique, described by Jobsis and co-workers (19), has been used to detect changes in HbO2 content in vivo (19, 20). A diode-array UV-visible spectrophotometer (model 8452A; Hewlett-Packard, Waldbronn, Germany) equipped with a remote reflectance fiberoptic probe (model RSA-HP-84F; Labsphere, North Sutton, NH) was used to detect relative changes in tissue HbO2 levels. The relative HbO2 content of the ileal tissues was determined from the difference in the absorbance of incident light (deuterium lamp, 190-820 nm) measured simultaneously at a wavelength of 580 nm and at a nearby, neutral (isosbestic) wavelength (570 nm) (19). Measurements made at 580 nm reflect changes in the relative HbO2 content as well as changes in relative blood volume. Measurements made at 570 nm reflect changes in relative blood volume only, as this is an isosbestic wavelength with regard to changes in HbO2 and is thus unaffected by oxygenation status (19).
Relative HbO2 contents were expressed as a percentage of the
maximal measurable range, established by making similar measurements with the animal breathing an FIO2 of 1.0 at baseline (most oxygenated condition) and by excising the complete ileal segment at the
end of the experiment (i.e., no further blood flow) and making measurements until tissue oxygen extraction had ended (least oxygenated
condition). The latter condition was verified in several (but not all)
experiments by ventilating the animal with an FIO2 of 0 (100% N2) and
making measurements before the
dropped below 60 mm Hg,
yielding the same results. To standardize the results, the measurements made during no ileal blood flow were used when determining
the least oxygenated condition of the measurable range.
Ileal Perfusion Determinations with Colored Microspheres
The technique of measuring tissue perfusion by the use of colored microspheres as described and validated by Kowallik and colleagues (21) was used. Briefly, at the end of the 2 h experimental period, monochromatic microspheres (yellow; 15 µm in diameter, approximately 1.0 × 105/g of ileum) (Dye-Trak; Triton Technology, San Diego, CA) were injected into the superior mesenteric artery catheter supplying the ileal preparation and flushed with buffered isotonic saline. At the end of the experiment, multiple pieces of ileum (~ 2-3 g) were removed at random locations along the remaining intact ileal segment, and the mucosal and muscularis layers were separated from each other in all pieces and weighed.
The tissue samples were digested in 4 M KOH at 72° C for 4 h, and the colored microspheres were then recovered from the tissues by filtering the mix with a polyester microfilter (pore size of 10 µm). The microfilter, along with the trapped microspheres, was carefully placed into a microcentrifuge tube, mixed with 600 µl of dimethylformamide, and centrifuged at 2,000 × g for 3 min. The extracted dye was measured spectrophotometrically (absorbance at 448 nm) and compared with a standard curve to determine its relative concentration. The concentration of dye correlates directly with blood flow over a clinically relevant range [0-1,000 (ml/min)/kg] (21). The blood flow to the mucosal and muscularis samples correlates with the dye concentration per kilogram of tissue and the measured blood flow [(ml/min)/kg] at the time of injection of the microspheres.
Tissue Processing for Electron Microscopy
Ileal tissue samples were obtained for electron microscopy processing and evaluation at baseline and again at 2 h posttreatment. Each time, ~ 1.0- to 1.5-cm pieces of ileum were taken from either end of the intact segment. Several cross-sectional rings (~ 2-3 mm wide) of ileal tissue were excised from the proximal ends of these pieces (i.e., away from the ligature), diced further along their longitudinal axes, and immediately submerged into isotonic fixative (4% paraformaldehyde, 2.5% glutaraldehyde, and 0.1 M sucrose in 0.1 M phosphate buffer, pH 7.4) for approximately 2 h at room temperature. The tissue was then minced such that longitudinal sections through the villi were easily obtained. Tissue pieces were then repeatedly rinsed in isotonic buffer (0.1 M sucrose in 0.1 M phosphate buffer, pH 7.4), postfixed in 1% osmium tetroxide in rinse buffer for 1 h at room temperature, rinsed again in rinse buffer, and stored overnight at 4° C. The next morning, the tissue pieces were allowed to come to room temperature, then dehydrated through an ascending series of ethanol solutions. After rinsing with propylene oxide, they were infiltrated with and embedded in Spurr medium which then polymerized overnight at 60° C. The next day, thin sections (~ 80-90 nm) were cut on a Reichart Ultracut E microtome, mounted on copper grids, stained with 2% uranyl acetate and Reynolds lead citrate, and then later examined using a Phillips CM-12 transmission electron microscope at 60 kV.
Mitochondrial Injury Determinations
Mitochondrial ultrastructure was evaluated by electron microscopy at three different locations within each ileal sample. Specifically, mitochondrial ultrastructure was analyzed within the villus tips, villus crypts, and the circumferential muscle layer. These sites were selected because of their relative susceptibilities to injury (e.g., the villus tips are more prone to various forms of injury than are other mucosal structures) and their unique morphological and functional characteristics (i.e., mucosal tissue has different characteristics than does smooth muscle). Mitochondrial ultrastructure was examined at three randomly selected and widely separated areas at each of these three locations on two different grids prepared from samples obtained at each time point. Examinations were made in a blinded fashion by two reviewers, and the severity of ultrastructural injury was quantified by determining a composite score (based on the scale of 0-5 as shown in Table 1) that represented all of the mitochondria visualized within the microscopy field. Thus, each reviewer had six total evaluations of mitochondrial injury made at each of the three locations (i.e., tips, crypts, and muscle) per time point. The results obtained by the two reviewers were pooled to yield a mean mitochondrial injury score at each of the three locations for each sample.
|
A strategy designed to grade consistently the severity of mitochondrial ultrastructural injury was established. It was derived from a scoring system based on the progressive stages of cellular injury, as described by Trump and colleagues (22). This staging system enumerates the characteristic progression of ultrastructural changes that occurs within cells in various models of inflammatory injury (e.g., ischemia- reperfusion). The association between the degree of mitochondrial injury and the defined stages of cellular injury (Table 1) was employed to quantify and standardize the severity of ultrastructural injury to the ileal mitochondria.
Ileal
O2-
O2 Determinations
Superior mesenteric blood flow was sequentially decreased from
baseline in a stepwise manner (i.e., ~ 1- to 2-ml/min decrements) to
approximately 10% of baseline, using a variable resistance clamp in the
arterial circuit. After each decrement in blood flow, at least 5 min was
allowed for equilibration, and then systemic arterial and ileal venous
blood samples were obtained and immediately analyzed for their oxygen contents. The measured superior mesenteric venous blood flow
and oxygen contents were used to calculate ileal
O2 and
O2 according to the Fick equation. Ileal
O2-
O2 relationships were analyzed
using least-squares regression to determine the critical thresholds for
oxygen delivery (
O2c) and oxygen consumption (
O2c), as described
previously (6). Finally, using the ratio of
O2 to
O2 at the minimal oxygen delivery (i.e., the lowest blood flow) and at the
O2c, the
maximum oxygen extraction (O2ERm) and critical oxygen extraction
(O2ERc) were determined, respectively.
Statistical Analyses
All data are expressed as means ± SEM. Relationships between
O2
and
O2 were determined using linear regression. The critical threshold for oxygen delivery (
O2c) was obtained using least-squares regression, as described previously (6). Values for
O2c,
O2c, O2ERm,
and O2ERc were compared using a one-way analysis of variance
(ANOVA) (23). Comparisons of hemodynamic and arterial blood parameters, relative HbO2 contents and other spectrophotometric measurements, ileal perfusion distributions, and mitochondrial injury
were made using a one-way ANOVA (treatment) with repeated measures (time). Post hoc analyses between group means at specific time
points were performed using the Fisher test for least significant difference, which takes into consideration interactions due to multiple comparisons (23). Finally, relationships between mitochondrial injury and
O2c and O2ERm were determined using linear regression and tested
statistically by employing the Spearman correlation for bivariate
analyses (23). Significance was based on a value of p
0.05.
| |
RESULTS |
|---|
|
|
|---|
Hemodynamic and Arterial Blood Parameters
At 2 h posttreatment, no significant differences were observed between the two groups with respect to either the measured arterial-venous pressure difference or the total blood flow across the ileal preparation (Table 2). In addition, the calculated vascular resistance in the ileum of the LPS-treated group was remarkably similar at 2 h to that of the control group. Although the LPS-treated animals required greater volume resuscitation relative to time-matched control animals (32 ± 3 versus 79 ± 8 ml; control versus LPS-treated animals, p < 0.01), arterial Hb concentrations and measured O2 contents were not significantly different between the two groups and remained somewhat constant over time compared with baseline (Table 2). Furthermore, the arterial pH was well maintained over time compared with baseline and relatively consistent between the groups at 2 h (Table 2). However, the LPS-treated group required significantly greater amounts of administered bicarbonate to maintain the pH over time (10.8 ± 1.3 versus 17.3 ± 1.8 mEq; control versus LPS-treated animals, p < 0.01).
|
Ileal Oxyhemoglobin Contents
In vivo spectrophotometric measurements of relative HbO2 contents changed little over 2 h, with control animals averaging nearly 97% and LPS-treated animals maintaining more than 92% of baseline values. Furthermore, there was no significant difference in the relative HbO2 contents between the two groups at 2 h (Figure 1). The maximum absorbances for the control group (1.112 ± 0.097 and 1.098 ± 0.098 absorbance units [AU] at 580 and 570 nm, respectively) and the LPS-treated group (1.076 ± 0.033 and 1.061 ± 0.032 AU at 580 and 570 nm, respectively) were essentially the same for each group. Likewise, the minimum absorbances for the control group (0.800 ± 0.068 and 0.827 ± 0.068 AU at 580 and 570 nm, respectively) and the LPS-treated group (0.876 ± 0.037 and 0.902 ± 0.036 AU at 580 and 570 nm, respectively) were similar between the groups. Most importantly, the overall maximal measurable change in absorbance between the most and least oxygenated states was not significantly different between the two groups (0.042 ± 0.008 versus 0.041 ± 0.003 AU; control versus LPS) and was similar to that shown by other investigators (19). In addition, measurements made at 570 nm (which reflect relative changes in blood volume) were not significantly different at baseline (1.011 ± 0.055 versus 1.075 ± 0.035 AU; control versus LPS), and increased to 112.7 ± 1.6 and 106.0 ± 3.6% of baseline at 2 h in the control and LPS-treated groups, respectively.
|
To obtain the relative HbO2 content in vivo during the
least oxygenated state, measurements were made in the setting of no ileal blood flow (as described in METHODS). These
measurements were verified by comparing them with those
made while ventilating the animals with an FIO2 of 0, which
yielded similar results. Namely, the difference in the absorbance measured at 570 nm and simultaneously at 580 nm was
0.027 ± 0.003 AU in the absence of blood flow and
0.025 ± 0.004 AU for an FIO2 of 0. Correspondingly, this measurement
was
0.027 ± 0.005 AU for controls and
0.026 ± 0.002 AU
for the LPS-treated group. These measurements were consistent with those found by Jobsis and coworkers (19).
Ileal Perfusion Measurements
Measurements of the distribution of ileal blood flow to the mucosal and muscularis layers using colored microspheres demonstrated no significant difference over time from baseline or between the two groups at 2 h (Figure 2). Most importantly, the results showed that mucosal blood flow was maintained at 2 h, presenting no measurable evidence of shunting toward the muscularis layer after treatment with LPS.
|
Ileal
O2-
O2 Relationships
As expected, on the basis of our previous experience with this
model (7, 8), LPS treatment was associated with altered oxygen metabolism in the ileum after 2 h. Specifically, the LPS-treated group demonstrated a dramatic elevation in the ileal
O2c [25.1 ± 1.7 versus 18.3 ± 0.2 (ml/min)/kg; p < 0.01] and a
significantly impaired ileal O2ERm (60.2 ± 2.3 versus 74.1 ± 3.6%; p < 0.01) relative to time-matched control animals. Likewise, LPS treatment was associated with a significant decrease
in the ileal O2ERc (47.9 ± 3.9 versus 63.1 ± 4.6%; LPS-treated
versus control animals, p < 0.01). In addition, although not
significantly different, the ileal
O2c was slightly higher after
LPS treatment compared with control animals (12.2 ± 0.6 versus 11.0 ± 0.7 (ml/min)/kg, respectively].
Mitochondrial Ultrastructure
LPS-treated animals demonstrated significant mitochondrial ultrastructural injury in the ileal mucosa relative to time-matched control animals (Figures 3 and 4). Although mitochondrial injury varied from mild to profoundly severe in the LPS-treated animals, on average, LPS treatment was associated with significant swelling of all intramitochondrial spaces, including the cristae (Figure 3). In the more severe instances, mitochondrial swelling was often accompanied by a disruption in membrane integrity as well. However, there were no significant differences in the relative presence or severity of mitochondrial injury between the ileal villus tips and crypts for either group. Thus, the results from these two locations were pooled for comparison of mitochondrial injury between the groups (Figure 4). In contrast to the findings in the mucosal layer, no significant change in mitochondrial ultrastructure was noted in the muscularis layer of the ileum over time or between groups. Finally, no evidence of mitochondrial injury was observed in any of the control ileal samples (Figures 3 and 4).
|
|
Bivariate analysis of the parameters of oxygen metabolism
and the corresponding degree of mitochondrial injury determined at 2 h established significant and noteworthy correlations. Specifically, a positive correlation existed between the
O2c and mitochondrial injury (Figure 5); whereas a negative
correlation existed between the O2ERm and mitochondrial injury (Figure 6).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The cause of organ dysfunction in sepsis is unknown. However, sepsis-induced disruption of oxygen metabolism is commonly observed and is believed to play a critical role in the
pathogenesis of organ dysfunction (4, 5). The manifestations
of sepsis-induced alterations of oxygen metabolism have been
well documented both clinically (4, 5) and experimentally (7,
8). Namely, abnormal
O2-
O2 relationships in sepsis are
characterized by impaired tissue oxygen extraction, elevated
tissue
O2, and a dependency of
O2 on
O2 over a broad
range of oxygen deliveries (4, 5). Moreover, the fact that
O2
is dependent on
O2 at higher than normal oxygen deliveries
suggests that the tissues are anaerobic, a notion supported by
the observation that tissue acidosis (11), hyperlactatemia (13),
and abnormal
O2-
O2 relationships (7) coexist in sepsis.
Our experiments (6) and those of others (9) provide
evidence that impaired tissue oxygen delivery may not be sufficient to explain altered oxygen metabolism during sepsis. In
this regard, several studies (9) have demonstrated that tissue oxygen levels actually increase during sepsis. In addition,
the intestinal mucosal layer has been shown to demonstrate
persistent lactatemia and acidosis (signs of increased anaerobic respiration) despite increases in mucosal oxygen concentrations (11) and mucosal blood flow (12). Likewise, using the
in situ autoperfused feline ileal preparation employed in this
study, we have shown that microvascular injury, combined
with conditions favoring tissue edema formation (i.e., the putative causes of impaired oxygen delivery to the tissues), does
not result in altered
O2-
O2 relationships (6). Furthermore,
in LPS-treated animals, the severity of microvascular injury in
the ileum does not correlate with the development of ileal
O2-
O2 alterations (7). Taken together, these studies suggest that impaired oxygen use, rather than insufficient oxygen delivery, may be responsible for the
O2-
O2 alterations in sepsis.
On the basis of these observations, it follows that the principal oxygen-consuming organelles (e.g., mitochondria) may be injured in the tissues during sepsis or after LPS administration. Indeed, in a primate model of gram-negative sepsis, Simonson and coworkers have shown that mitochondrial morphology and function were impaired in skeletal muscle of the forearm (24). Moreover, using models of septic shock in which no attempt was made to maintain adequate tissue perfusion, others have demonstrated the presence of mitochondrial injury in various systemic organs (17, 18). By optimizing tissue perfusion (i.e., minimizing ischemia) and measuring parameters of tissue oxygen metabolism, the present study provides further insights into the pathogenesis of mitochondrial injury in the ileum during sepsis. The functional status of the ileum is of particular interest owing to its putative role in the perpetuation of a systemic inflammatory state during critical illness, as in sepsis (3).
In this study, we have demonstrated that time-dependent
alterations in ileal oxygen metabolism correlate with the development of ileal mitochondrial ultrastructural injury. Two
hours after LPS treatment, both
O2-
O2 alterations and mitochondrial injury (Figures 3 and 4) are present in the ileum.
In keeping with our original hypothesis, highly significant correlations exist between variables of altered ileal oxygen metabolism and the severity of ileal mitochondrial injury (Figures 5 and 6). Importantly, LPS-induced alterations in ileal
oxygen metabolism and mitochondrial ultrastructure occur
despite unchanged relative ileal HbO2 contents (Figure 1) and
ileal mucosal blood flow distributions (Figure 2). Although
these organ-specific indices of oxygen availability to the tissues cannot absolutely exclude the potential existence of microregional tissue hypoxia, the experiments were designed to
carefully minimize and examine for the presence of tissue hypoxia and ischemia. Accepting the current technical limitations
for measuring oxygen delivery and content in living tissue, the
results of this study and of other investigations (10) provide compelling evidence suggesting that inadequate oxygen
delivery to the tissues may not be the primary cause of altered
oxygen metabolism in the ileum during sepsis.
If, as these findings suggest, tissue hypoxia is not the proximal cause of mitochondrial injury and altered oxygen metabolism in sepsis, then what is? One possible explanation evokes
reactive oxygen intermediates (ROIs) as a cause of impaired
mitochondrial function during acute inflammatory injury.
Namely, various ROIs are known to be produced in tissues in
models of sepsis (25), including superoxide anion (25, 26)
and nitric oxide (NO) (27, 28). These ROIs could cause mitochondrial dysfunction resulting in impaired oxygen use and consequent oxygen metabolism alterations. In this regard, ROIs
can inhibit mitochondrial oxidative phosphorylation (29),
in turn, leading to increased formation of further ROIs (30).
Besides potentially causing further mitochondrial damage
and/or dysfunction, these ROIs, combined with the impaired electron flow through the inhibited electron transport chain, would result in less efficient oxygen use. Thus, ROI-induced
mitochondrial inhibition could explain why the ileum was less
effective in using the oxygen available to it (i.e., decreased
O2ERm) in this model of sepsis. Regardless of the oxygen-consuming pathways functioning in this setting (e.g., oxidative
phosphorylation, ROI formation), in the absence of a reduction in
O2 (as was the case for the LPS-treated group), a decrease in oxygen extraction by the tissues would result in an
increase in the critical
O2 (as demonstrated in the present
study). To the extent that mitochondrial impairment results in
inefficient oxygen use and additional ROI production during
sepsis, mitochondrial inhibition could explain why augmenting oxygen delivery often fails to improve outcome in patients
with established sepsis (14, 15).
Nitric oxide is a ROI that may play a critical role in sepsis-induced alterations of oxygen metabolism. NO alone (31, 32) or in combination with superoxide (29, 30) (i.e., peroxynitrite, the reactive product of NO and superoxide [29, 30, 33]) is
known to impair mitochondrial oxygen consumption through
inhibition of oxidative phosphorylation. Indeed, NO overproduction, as is seen during sepsis (27, 28), is capable of causing
cell death associated with profound mitochondrial injury (34).
A potential association between LPS-induced NO dysregulation and mitochondrial injury is supported by observations in
our laboratory. Specifically, the severity of ileal mitochondrial
injury correlated with the immunoprevalence of inducible nitric oxide synthase and 3-nitrotyrosine (indicates nitrosylation
of tyrosine residues on proteins due to peroxynitrite) staining
in ileal tissues (35). Despite these observations, the role of NO
and other ROIs in the pathogenesis of
O2-
O2 alterations
and mitochondrial injury remains undefined.
In summary, this study is provocative in that the results demonstrate a strong statistical correlation between mitochondrial injury and altered oxygen metabolism during sepsis. Although regional measures of oxygen delivery and blood flow distribution were unchanged from baseline in the LPS-treated group, the existence of microregional blood flow heterogeneity (i.e., hypoxia) was difficult to exclude owing to the limitations of current techniques for in vivo tissue oxygen measurement. Nonetheless, the results of this study are significant in that, regardless of the cause, mitochondrial injury occurred in the ileum despite efforts to provide sufficient oxygen to the tissues. Moreover, to the extent that the observed association between mitochondrial injury and altered oxygen metabolism reflects a causal relationship, an answer to the paradox regarding oxygen metabolism during sepsis may be provided. Namely, signs of anaerobic metabolism (e.g., tissue acidosis) develop in the gut during sepsis despite increased tissue oxygen content (10, 11) and increased tissue oxygen delivery (12). These observations are consistent with the possibility that impaired ileal oxygen use results from mitochondrial injury during sepsis. Mitochondrial dysfunction may also explain the results of large, well-designed clinical trials demonstrating no benefit to increasing systemic oxygen delivery in patients with established sepsis (14, 15). However, although the present study showed a significant association between mitochondrial injury and oxygen metabolism abnormalities in sepsis, causality was not demonstrated, and the mechanisms responsible for these findings remain unclear. Future investigations into the causes of mitochondrial injury during sepsis may lead to the development of new approaches to the treatment of critically ill patients presenting with oxygen metabolism alterations.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Elliott D. Crouser, M.D., Division of Pulmonary and Critical Care Medicine, The Ohio State University Medical Center, N325 Means Hall, 1654 Upham Drive, Columbus, OH 43210. E-mail: Crouser-1{at}medctr.osu.edu
(Received in original form October 29, 1998 and in revised form March 8, 1999).
Acknowledgments: Supported by NIH Grant HL41366-01A, ALA Grant RG-038-N, and an OSU Seed Grant.
| |
References |
|---|
|
|
|---|
1. Centers for Disease Control. 1990. Increase in national hospital discharge rates for septicemia: United States, 1970-1987. M.M.W.R 39: 31-34 [Medline].
2. Bone, R. C., C. J. Fisher Jr., T. P. Clemmer, G. J. Slotman, G. J. Metz, and R. A. Balk. 1987. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317: 653-658 [Abstract].
3. Carrico, C. J., J. L. Meakins, J. C. Marshall, D. Fry, and R. V. Maier. 1986. Multiple-organ-failure syndrome. Arch. Surg. 121: 196-208 [Medline].
4. Gutierrez, G., and R. J. Pohil. 1986. Oxygen consumption is linearly related to oxygen supply in critically ill patients. J. Crit. Care 1: 45-53 .
5. Weg, J. G.. 1991. Oxygen transport in adult respiratory distress syndrome and other acute circulatory problems: relationship of oxygen delivery and oxygen consumption. Crit. Care Med. 19: 650-657 [Medline].
6.
Crouser, E. D.,
M. W. Julian,
S. E. Weisbrode, and
P. M. Dorinsky.
1996.
Acid aspiration results in ileal injury without altering ileal
O2-DO2
relationships.
Am. J. Respir. Crit. Care Med.
153:
1965-1971
[Abstract].
7. Crouser, E. D., M. W. Julian, S. E. Weisbrode, and P. M. Dorinsky. 1997. Endotoxin-induced ileal VO2-DO2 alterations do not correlate with the severity of ileal injury. J. Crit. Care 12: 83-91 [Medline].
8. Crouser, E. D., M. W. Julian, S. E. Weisbrode, and P. M. Dorinsky. 1997. Ischemia/reperfusion injury to the ileum does not account for the ileal VO2-DO2 alterations induced by endotoxin. J. Crit. Care 12: 200-207 [Medline].
9. Schaefer, C. F., M. R. Lerner, and B. Biber. 1991. Dose-related reduction of intestinal cytochrome a1a3 induced by endotoxin in rats. Circ. Shock 33: 17-25 [Medline].
10. Boekstegers, P., S. Weidenhofer, T. Kapsner, and K. Werdan. 1994. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit. Care Med. 22: 640-650 [Medline].
11. VanderMeer, T. J., H. Wang, and M. P. Fink. 1995. Endotoxin causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit. Care Med. 23: 1217-1226 [Medline].
12. Revelly, J. P., T. Ayuse, N. Brienza, H. E. Fessler, and J. L. Robotham. 1996. Endotoxic shock alters distribution of blood flow within the intestinal wall. Crit. Care Med. 24: 1345-1351 [Medline].
13. Mizock, B.. 1984. Septic shock: a metabolic perspective. Arch. Intern. Med. 144: 579-585 [Medline].
14.
Hayes, M. A.,
A. C. Timmins,
E. H. S. Yau,
M. Palazzo,
C. J. Hinds, and
D. Watson.
1994.
Elevation of systemic oxygen delivery in the treatment of critically ill patients.
N. Engl. J. Med.
330:
1717-1722
15.
Gattinoni, L.,
L. Brazzi,
P. Pelosi,
R. Latini,
G. Tognoni,
A. Pesenti, and
R. Fumagalli.
1995.
A trial of goal-oriented hemodynamic therapy in
critically ill patients.
N. Engl. J. Med.
333:
1025-1032
16. Kudoh, A., E. Kudoh, H. Ishahari, and A. Matsuki. 1998. ONO-5046, an elastase inhibitor, attenuates liver mitochondrial dysfunction after endotoxin. Crit. Care Med. 26: 138-141 [Medline].
17. Welty-Wolf, K. E., S. G. Simonson, Y. C. Huang, P. J. Fracica, J. W. Patterson, and C. A. Piantadosi. 1996. Ultrastructural changes in skeletal muscle mitochondria in gram-negative sepsis. Shock 5: 378-384 [Medline].
18. Bende, S., Jr., L. Bertok, and S. Bende. 1992. Protective effect of radio-detoxified endotoxin (Tolerin) on the ultrastructure of pancreas in experimental endotoxin shock of rats. Acta Chirurgica Hungarica 33(1- 2):197-208.
19.
Jobsis, F. F.,
J. H. Keizer,
J. C. LaManna, and
M. Rosenthal.
1977.
Reflectance spectrophotometry of cytochrome aa3 in vivo.
J. Appl. Physiol.
43:
858-872
20. Sato, N., N. Hayashi, S. Kawano, T. Kamada, and H. Abe. 1983. Hepatic hemodynamics in patients with chronic hepatitis or cirrhosis as assessed by organ-reflectance spectroscopy. Gastroenterology 84: 611-616 [Medline].
21. Kowallik, P., R. Schulz, B. D. Guth, A. Schade, W. Paffhausen, R. Gross, and G. Heusch. 1991. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 83: 974-982 [Medline].
22. Trump, B. F., I. K. Berezesky, K. U. Laiho, A. R. Osornio, W. J. Mergner, and M. W. Smith. 1980. The role of calcium in cell injury: a review. Scan. Electron. Microsc. 2: 437-462 .
23. Sokal, R. R., and F. J. Rohlf. 1981. Biometry, 2nd edition. W. H. Freeman & Co., New York. 242-262, 324-344, and 606-616.
24. Simonson, S. G., K. Welty-Wolf, Y. T. Huang, J. A. Griebel, M. S. Caplan, P. J. Fracica, and C. A. Piantadosi. 1994. Altered mitochondrial redox responses in gram negative septic shock in primates. Circ. Shock 43: 34-43 [Medline].
25. Supinski, G., D. Nethery, and A. Dimarco. 1993. Effect of free radical scavengers on endotoxin-induced respiratory muscle dysfunction. Am. Rev. Respir. Dis. 148: 1318-1324 [Medline].
26.
Hennet, T.,
C. Richter, and
E. Peterhans.
1993.
Tumor necrosis factor-
induces superoxide anion generation in mitochondria of L929 cells.
Biochem. J.
289:
587-592
.
27. Chen, K., M. Inoue, and A. Okada. 1996. Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem. Biophys. Res. Commun. 224: 703-708 [Medline].
28. Yen, M. H., Y. C. Liu, H. J. Hong, J. R. Sheu, and C. C. Wu. 1997. Role of nitric oxide in LPS-induced mortality from spontaneously hypertensive rats. Life Sci. 60: 1223-1230 [Medline].
29. Lizasoain, I., M. A. Moro, R. G. Knowles, V. Darley-Usmar, and S. Moncada. 1996. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 314: 877-880 .
30. Poderoso, J. J., M. C. Carreras, C. Lisdero, N. Riobo, F. Schopfer, and A. Boveris. 1996. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328: 85-92 [Medline].
31. Brown, G. C., J. P. Bolanos, S. J. R. Heales, and J. B. Clark. 1995. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193: 201-204 [Medline].
32. Brown, G. C.. 1995. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369: 136-139 [Medline].
33. Packer, M. A., C. M. Porteous, and M. P. Murphy. 1996. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem. Mol. Biol. Int. 40: 527-534 [Medline].
34. Mitrovic, B., L. J. Ignarro, H. V. Vinters, M. A. Akers, I. Schmid, C. Uittenbogaart, and J. E. Merrill. 1995. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65: 531-539 [Medline].
35. Crouser, E. D., M. W. Julian, P. M. Dorinsky, and J. A. Bauer. 1998. Endotoxin (LPS)-induced mitochondrial injury in the ileum correlates with nitric oxide (NO) dysregulation. Am. J. Respir. Crit. Care Med. 157: A104 .
This article has been cited by other articles:
![]() |
L. A. Callahan and G. S. Supinski Diaphragm and cardiac mitochondrial creatine kinases are impaired in sepsis J Appl Physiol, January 1, 2007; 102(1): 44 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Porta, J. Takala, C. Weikert, P. Kaufmann, S. Krahenbuhl, and S. M. Jakob Effect of endotoxin, dobutamine and dopamine on muscle mitochondrial respiration in vitro Innate Immunity, December 1, 2006; 12(6): 358 - 366. [Abstract] [PDF] |
||||
![]() |
M. S. Joshi, M. W. Julian, J. E. Huff, J. A. Bauer, Y. Xia, and E. D. Crouser Calcineurin Regulates Myocardial Function during Acute Endotoxemia Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 999 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Callahan and G. S. Supinski Sepsis Induces Diaphragm Electron Transport Chain Dysfunction and Protein Depletion Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 861 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Callahan and G. S. Supinski Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis J Appl Physiol, September 1, 2005; 99(3): 1120 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lobo, D. De Backer, Q. Sun, Z. Tu, G. Dimopoulos, J.-C. Preiser, N. Nagy, B. Vray, V. Vercruy, R. G. G. Terzi, et al. Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemia J Appl Physiol, November 1, 2003; 95(5): 2047 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morita, I. Chin-Yee, P. Yu, W. J. Sibbald, and C. M. Martin Critical Oxygen Delivery in Conscious Septic Rats under Stagnant or Anemic Hypoxia Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 868 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. CROUSER, M. W. JULIAN, D. M. WEINSTEIN, R. J. FAHY, and J. A. BAUER Endotoxin-induced Ileal Mucosal Injury and Nitric Oxide Dysregulation Are Temporally Dissociated Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1705 - 1712. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |